News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
Bacterin Prices $65 Million Of 6.00% Convertible Senior Notes 7/28/2015
Cara Therapeutics, Inc. (CARA) Announces Proposed Offering Of Common Stock 7/28/2015
Anatara Lifesciences Closes Heavily Subscribed Share Purchase Plan 7/28/2015
Dynavax Technologies Corporation (DVAX) Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock 7/28/2015
DelMar Pharmaceuticals Announces Financing Update And Initial Subscriptions Of $2.0 Million In Registered Direct Offering 7/28/2015
Quest PharmaTech Inc. Closes $1,000,000 Private Placement 7/28/2015
Mylan (MYL) Announces Meeting Date And Record Date Of Extraordinary General Meeting Of Shareholders 7/28/2015
Egalet Announces Proposed Public Offering Of Common Stock 7/28/2015
ESSA Pharma To Commence Trading On The Toronto Stock Exchange 7/28/2015
Tissue Therapies Change In Strategy And Development Of Vitrogro As A Pharmaceutical Worldwide 7/28/2015
Amyris, Inc. Signing Of Agreements For Conversion And Restructuring Of Approximately $175 Million Of Convertible Debt And $25 Million Private Placement 7/27/2015
Paratek Pharmaceuticals, Inc. Announces Termination Of Tax Benefit Preservation Plan 7/27/2015
BioMarin (BMRN) Joins The NASDAQ-100 Index 7/27/2015
Hemispherx Biopharma (HEB) To Host Stockholder Open House At Manufacturing And Research Facility In New Jersey 7/27/2015
ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting 7/27/2015
Drugs Trump Tech As Investors Shift Earnings Bets To Healthcare 7/24/2015
Cancer Genetics, Inc. (CGIX) Announced Today That It Has Suspended Its Activity On The "At-The-Market" Equity Offering 7/24/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 7/24/2015
ViewRay Completes Alternative Public Offering, Raises $26.7 Million 7/24/2015
CryoPort, Inc. Announces Pricing Of Public Offering Of Units And Listing On NASDAQ 7/24/2015
Vista Partners Initiates Coverage On Immune Pharmaceuticals, Inc. (NasdaqCM: IMNP); $6.00 Price Target 7/24/2015
CytRx Corporation (CYTR) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/24/2015
Biogenerator Makes Investment In Confluence Life Sciences 7/24/2015
Deutsche Biotech Innovativ AG: AGM Approves Bonus Shares And Capital Increase 7/24/2015
Exelixis (EXEL) Prices Public Offering Of Common Stock 7/24/2015
PerkinElmer (PKI) Board Declares Quarterly Dividend 7/24/2015
Radius Health (RDUS) Announces Pricing Of Public Offering 7/23/2015
Pressure BioSciences, Inc. (BBII) Closes $2,180,000 Initial Tranche Of A $5 Million Private Placement 7/23/2015
Discovery Laboratories (DSCO) Announces Completion of $40.25 Million Public Offering 7/23/2015
Abcam Inc.: Pre-Close Trading Update 7/23/2015
Allergy Therapeutics plc: Notice of Results and Trading Update 7/23/2015
Integrity Applications, Inc. Announces Adjournment Of Annual Meeting 7/23/2015
NephroGenex (NRX) Announces Closing Of Public Offering Of Common Stock And Warrants 7/23/2015
BioLight Announces Upcoming Change Of ADS Conversion Ratio 7/23/2015
Mad Money’s Jim Cramer Wants Johnson & Johnson (JNJ) Busted Into Three Companies 7/22/2015
Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital 7/22/2015
NeuroDerm (NDRM) Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
Radius Health (RDUS) Announces Proposed Public Offering 7/22/2015
Fibrocell Science, Inc. Announces Proposed Public Offering Of Common Stock 7/22/2015
Achaogen (AKAO) Announces Employment Inducement Grants 7/22/2015
Ultragenyx Pharmaceuticals (RARE) Announces Closing Of Public Offering Of Common Stock And Exercise Of Underwriters' Option To Purchase Additional Shares 7/22/2015
Fibrocell Science, Inc. Announces Pricing Of Public Offering Of Common Stock 7/22/2015
Sunshine Heart Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7/22/2015
RedHill Biopharma Ltd. (RDHL) Announces Closing Of Public Offering Of Its American Depository Shares 7/22/2015
ProNAi Therapeutics, Inc. Announces Closing Of IPO And Full Exercise Of The Underwriters' Option To Purchase Additional Shares 7/22/2015
TrovaGene, Inc. Announces Closing Of Public Offering Of Common Stock 7/22/2015
Dynavax Technologies Corporation (DVAX) Prices Public Offering Of Common Stock 7/22/2015
Exelixis (EXEL) Launches Proposed Public Offering Of Common Stock 7/22/2015
Motif Bio plc Release: Final Condition Of £22 Million Placing Satisfied With FDA QIDP Designation For iclaprim 7/22/2015
Flamel Technologies (FLML) Announces Results Of 2015 Annual Meeting; Domestic U.S. Public Company Reporting Status To Begin In 2016 7/22/2015
Polydex Pharmaceuticals (POLXF) Extends Invitation To AGM And Advises On Voting Procedures 7/21/2015
EXACT Sciences (EXAS) Announces Pricing Of Public Offering Of Common Stock 7/21/2015
Synthetic Biologics, Inc. (SYN) Announces Closing Of Recent Equity Offering And Exercise In Full Of Underwriters' Over-Allotment Option 7/21/2015
CytRx Corporation (CYTR) Announces Pricing Of Public Offering Of 9.1 Million Shares Of Common Stock 7/21/2015
Horizon Pharma (HZNP) Increases Offer For Depomed (DEPO) To $33.00 Per Share 7/21/2015
Resverlogix (RVX.TO) Closes $50 Million Private Placement With Hepalink And Eastern Capital 7/21/2015
Dauntless Pharmaceuticals Launches New Company Focused On Developing A Portfolio Of Improved Therapeutics 7/21/2015
Protalex, Inc. (PRTX) Announces Listing On OTCQB Exchange 7/21/2015
CytRx Corporation (CYTR) Announces Proposed Public Offering Of Common Stock 7/21/2015
Antibe Therapeutics Inc. (ATE.V) Announces Addition Of Aspirin Derivative To Its Product Pipeline And Provides An Update On Validation Studies 7/21/2015
Depomed (DEPO) Confirms Receipt Of Purported Revised, Highly Conditional, Unsolicited Proposal From Horizon Pharma (HZNP) 7/21/2015
NOVACYT Release: Strong First-Half Revenues Completes €3.5 Million In Bond Refinancing And Launches A €1.7 Million Private Placement 7/20/2015
NuGene International Inc. Secures $301,450 Product Purchase Reorder From Leading Existing Distributor and Also Announces New Distributor With Initial Orders Exceeding $71,000 7/20/2015
Secondary Placing Of Ordinary Shares In ErgoMed 7/20/2015
Immune Pharmaceuticals, Inc. Joins The Russell Microcap Index 7/17/2015
TrovaGene, Inc. Announces Public Offering Of Common Stock 7/17/2015
HEALTHSOUTH Increases And Declares Dividend On Common Stock 7/17/2015
Discovery Laboratories (DSCO) Announces Proposed Public Offering Of Common Stock, Warrants And Pre-Funded Warrants 7/17/2015
RedHill Biopharma Ltd. (RDHL) Prices Public Offering Of Its American Depository Shares 7/17/2015
NephroGenex (NRX) Prices $7,500,000 Public Offering 7/17/2015
Vermillion Announces Closing Of $18.8 Million Public Offering Of Common Stock 7/17/2015
Thermo Fisher Scientific (TMO) Prices Offering Of Euro-Denominated Senior Notes 7/17/2015
Cleveland Biolabs Inc. (CBLI) Announces Receipt Of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement 7/17/2015
TONIX Pharmaceuticals, Inc. (TNXP) Closes $20.1 Million Public Offering Of Common Stock 7/17/2015
Synthetic Biologics, Inc. (SYN) Announces Public Offering Of Common Stock 7/16/2015
ProNAi Therapeutics, Inc. Announces Pricing Of Initial Public Offering 7/16/2015
NeuroDerm (NDRM) Announces Pricing Of Public Offering 7/16/2015
Ultragenyx Pharmaceuticals (RARE) Announces Pricing Of Public Offering Of Common Stock 7/16/2015
Synthetic Biologics, Inc. (SYN) Announces Pricing Of $40.0 Million Public Offering 7/16/2015
Chiasma Prices Initial Public Offering Of Common Stock 7/16/2015
NovaBay (NBY) Plan Of Compliance Accepted By NYSE 7/16/2015
Delcath Systems (DCTH) Announces Pricing Of Public Offering 7/16/2015
GeneNews (GEN.TO) Announces Proposed Non-Brokered Private Placement 7/15/2015
Ultragenyx Pharmaceuticals (RARE) Announces Proposed Public Offering Of Common Stock 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Proposed Public Offering Of Its American Depository Shares 7/15/2015
Akorn, Inc. (AKN) Announces Nasdaq's Acceptance Of Its Plan To Regain Compliance 7/15/2015
BG Medicine (BGMD) Announces Payoff Of Secured Term Loan 7/15/2015
NewLink Genetics (NLNK) Shares Immuno-Oncology Vision At Investor Day 7/15/2015
RedHill Biopharma Ltd. (RDHL) Announces Size Of Proposed Public Offering Of Its American Depository Shares 7/15/2015
Cynata Completes Private Placement To U.S. Institutional Investors 7/15/2015
BTG plc (BTG.L): Annual General Meeting 7/15/2015
Avacta Group plc Release: Conditional Placing To Raise Up To £22.0 Million 7/15/2015
Atara Biotherapeutics (ATRA) Announces Closing Of Underwritten Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/15/2015
MediGene AG (MDGEF.PK): Notification § 27a 7/15/2015
SiteOne Therapeutics Secures Investment From Bozeman-Based Next Frontier Capital 7/15/2015
West Pharmaceutical Services Announces Increase To Quarterly Dividend 7/15/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Completion Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 7/14/2015
Vermillion Announces Proposed Public Offering Of Common Stock 7/14/2015
Vermillion Prices $16.4 Million Public Offering Of Common Stock 7/14/2015
TONIX Pharmaceuticals, Inc. (TNXP) Prices Underwritten Public Offering Of Common Stock 7/14/2015
MacroGenics, Inc. (MGNX) Announces Proposed Public Offering Of Common Stock 7/14/2015
TONIX Pharmaceuticals, Inc. (TNXP) Announces Proposed Public Offering Of Common Stock 7/14/2015
Aegerion (AEGR) Grants Stock Options Under Inducement Program 7/14/2015
K2M Announces Closing Of Sale Of Shares Of Common Stock 7/14/2015
Intuitive Surgical (ISRG) Reports New Employee Option Grants For July 2015 7/14/2015
Summit Therapeutics Annual General Meeting Statement 7/14/2015
Extraordinary General Meeting In Aerocrine AB 7/14/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Announces Shareholders And Board Of Directors Approval Of Reverse Stock Split 7/13/2015
Young Biotechs' Stock Market Rollercoaster 7/13/2015
Concordia Healthcare (CXR.TO) Announces Filing of Preliminary Base Shelf Prospectus 7/13/2015
Amarantus BioSciences, Inc. To Commence Trading On The OTCQX Marketplace Under Existing Ticker Symbol AMBS 7/13/2015
CureMark Secures $20 Million In Equity Financing 7/13/2015
Aethlon Medical (AEMD) Begins Trading On The Nasdaq Capital Market 7/13/2015
Becton, Dickinson and Company (BDX) Announces Sustainability Goals For 2020 7/13/2015
Hanger Inc. (Formerly known as Hanger Orthopedic Group, Inc.) (HGR) Announces The Successful Completion Of Senior Notes Consent Solicitation And Entry Into Supplemental Indenture 7/10/2015
Henry Schein, Inc. (HSIC) Invests In Romania's Maravet 7/10/2015
Urologix (ULGX) Announces SEC Deregistration 7/10/2015
PharmaCyte Biotech (NVLX) Appoints American Stock Transfer As New Stock Transfer Agent 7/10/2015
Atara Biotherapeutics (ATRA) Announces Pricing Of Its $180 Million Offering Of Common Stock 7/10/2015
StemCells (STEM) Clinical Programs Overview And Progress Update 7/10/2015
The Cooper Companies, Inc. (COO) Declares Cash Dividend 7/10/2015
Opko Health (OPK) Investee Scivac Announces The Completion Of Transaction With Levon Resources 7/10/2015
Thermo Fisher Scientific (TMO) Declares Quarterly Dividend 7/10/2015
Motif Bio Plc Release: Result Of General Meeting 7/10/2015
Clovis Oncology (CLVS) Announces Exercise In Full Of Underwriters’ Option To Purchase Additional Shares Of Common Stock 7/10/2015
TherapeuticsMD, Inc.  (TXMD) Announces Pricing Of Common Stock Offering 7/10/2015
Stellar Biotechnologies, Inc. Retains The Ruth Group To Advance Communications Objectives 7/10/2015
Merus Labs International Inc. Announces Filing of Preliminary Base Shelf Prospectus 7/10/2015
Ampio Pharmaceuticals, Inc. (AMPE) Announces Investor Call On Thursday, July 16, 4:30 p.m. EDT 7/9/2015
Celgene (CELG) Paid $93 Per Share For Juno Therapeutics (JUNO), But You're Only Willing To Pay $50? 7/9/2015
EXCLUSIVE: New Report Says Biosimilars Will Earn $55B by 2020, As Pfizer (PFE), Actavis (ACT), AbbVie (ABBV) Claim U.S. Market 7/9/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Proposed Public Offering Of Common Stock 7/9/2015
Anthera Pharmaceuticals, Inc. (ANTH) Announces Pricing Of Public Offering Of Common Stock 7/9/2015
BG Medicine (BGMD) Announces One-For-Four Reverse Stock Split 7/9/2015
Marrone Bio Innovations, Inc Provides Update On NASDAQ Matters And Financial Statement Review 7/9/2015
Medtronic (MDT) Continues to Develop Portfolio Amid Recall Issues 7/9/2015
Clovis Oncology (CLVS) Announces Pricing Of Public Offering Of Common Stock 7/9/2015
Karolinska Development AB Divests Its Holding In Pharmanest To An Investment Consortium Comprising Östersjöstiftelsen, Recipharm Venture Fund And Praktikerinvest 7/9/2015
Karolinska Development AB Implements A More Prudent And Representative Approach To Reporting The Fair Value Of Its Portfolio - Divestment Of Pharmanest 7/9/2015
Shareholders Support Management Proposals At SYGNIS ' AGM With Large Majority 7/9/2015
PROCEPT BioRobotics Snaps Up $42 Million In New Funding 7/8/2015
Resverlogix (RVX.TO) Closes License Agreement And Enters Into Definitive Stock Purchase Agreement With Shenzhen Hepalink Pharmaceutical Co., Ltd 7/8/2015
Atara Biotherapeutics (ATRA) Announces Proposed Offering Of Common Stock 7/8/2015
K2M Announces Pricing Of Sale Of Shares Of Common Stock 7/8/2015
K2M Announces Proposed Sale Of Shares Of Common Stock 7/8/2015
Aethlon Medical (AEMD) Announces Nasdaq Capital Market Listing Approval 7/8/2015
Prima Biomed (PRR.AX) Announces Share Purchase Plan 7/8/2015
EnteroMedics (ETRM) Announces Closing Of $16.0 Million Public Offering Of Common Stock And Warrants 7/8/2015
Sinovac Biotech Ltd. (SVA) Schedules 2015 Annual Meeting Of Shareholders 7/8/2015
EnteroMedics (ETRM) Announces Pricing Of $16.0 Million Public Offering Of Common Stock And Warrants 7/7/2015
EnteroMedics (ETRM) Announces Termination Of Public Offering Of Common Stock And Warrants 7/7/2015
Aytu BioScience Announces Stock Ticker Symbol Change 7/7/2015
Collegium (COLL) Added To Russell 2000, 3000 And Global Indexes 7/7/2015
BioRestorative Announces Reverse Stock Split In Preparation For Planned Uplisting To NASDAQ Capital Market 7/7/2015
Zogenix (ZGNX) To Host Key Opinion Leader Meeting Tuesday, July 14, In New York City 7/7/2015
Celator Pharmaceuticals, Inc. To Host Analyst And Investor Day On July 16, 2015 7/7/2015
Aimmune Therapeutics Files Registration Statement For Initial Public Offering 7/7/2015
Poxel 1H15 Cash And Turnover 7/7/2015
GenSpera Announces Private Placement Of $2.5 Million 7/7/2015
NeuroDerm (NDRM) Files Registration Statement For Proposed Follow-On Offering 7/6/2015
ESSA Pharma To Commence Trading On The NASDAQ Capital Market 7/6/2015
TiGenix: Notice In Relation To The Convertible Bonds Due 2018 7/6/2015
MediGene AG (MDGEF.PK): Medigene Announces Formal Closing Of Capital Measure 7/6/2015
OncoSec Medical Inc. To Ring The Nasdaq Stock Market Opening Bell 7/6/2015
EXCLUSIVE: More Details on Horizon For White Hot Gene Therapy M&A, Says Analyst 7/2/2015
Hologic (HOLX) Delivers Notice That Holders Of 2.00% Convertible Exchange Senior Notes Due 2037 Are Eligible To Convert 7/2/2015
Danaher (DHR) Announces Pricing of Euro-Denominated Senior Notes Offering 7/2/2015
AGTC (AGTC) To Host Conference Call And Webcast To Discuss Biogen (BIIB) Collaboration 7/2/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 7/2/2015
BiondVax Pharmaceuticals To Close Trading On NASDAQ On July 10, 2015 7/2/2015
SeaSpine Inc. Begins Trading On NASDAQ 7/2/2015
Cortendo Provides 2015 Half-Year Update On Corporate Progress 7/2/2015
Baxter International (BAX) Announces Early Results Of Debt Tender Offers 7/2/2015
Vetter Receives Re-Approval For Development Tax Credit From The French Ministry For Higher Education And Research 7/2/2015
Arch Therapeutics Announces Private Placement 7/2/2015
diaDexus Announces Reverse Stock Split 7/2/2015
Sarepta (SRPT) Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 7/1/2015
BioPharmX Corporation Closes Underwritten Public Offering Of Common Stock 7/1/2015
EndoChoice Announces Debt Refinancing 7/1/2015
Zynerba Files Registration Statement For Proposed Initial Public Offering Of Common Stock 7/1/2015
Senomyx, Inc. (SNMX) Announces Continued Inclusion In The Russell 2000 And Russell 3000 Indexes 7/1/2015
Discovery Laboratories (DSCO) Receives Nasdaq Notification Related To Minimum Bid Price 7/1/2015
Dynatronics Corporation (DYNT) Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 7/1/2015
Alder Biopharma Announces Exercise In Full Of Option To Purchase Additional Shares 7/1/2015
Resverlogix (RVX.TO) Shareholders Approve Matters Relating To Licensing And Equity Arrangement 7/1/2015
Conversion Right Extended On Opko Health (OPK) 3.0% Convertible Senior Notes 7/1/2015
Conversion Right Triggered For LabCorp (LH)’s Zero Coupon Convertible Subordinated Notes Due 2021 7/1/2015
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 7/1/2015
EXCLUSIVE: Gene Therapy M&A Booms, Increasing 40-Fold to $4.9 Billion 7/1/2015
Ignyta (RXDX) Added To Russell 2000 Index 6/30/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 6/30/2015
Change In Number Of Shares Outstanding In Sectra (SECTB) During June 6/30/2015
EnteroMedics (ETRM) Announces Pricing Of $35.0 Million Public Offering Of Common Stock And Warrants 6/30/2015
ViewRay Secures Up To $50M In Debt Financing From CRG 6/30/2015
Inari Medical Announces Closing Of $12.4 Million Venture Financing 6/30/2015
Asterias Biotherapeutics Added To Russell 2000, Russell 3000, Russell Global And Russell Microcap Indexes 6/30/2015
Affimed Therapeutics AG (AFMD) Added To Russell 2000(R) Index 6/30/2015
Agile Therapeutics, Inc. Added To Membership Of Russell 2000, 3000 And Global Indexes 6/30/2015
Alliqua Biomedical (ALQA) To Ring The Nasdaq Stock Market Opening Bell On July 6th 6/30/2015
Isis Pharma (ISIS) Promoted To The Large-Cap Russell 1000 Index 6/30/2015



//-->